Congress Returns Following Midterm Elections with Tight Deadline for Government Funding
2026 Midterm Election Results and Congressional Leadership Changes
The November 3 midterm elections shifted congressional control, with Democrats winning majorities in both the House and Senate for the 120th Congress. As of November 12, Democrats and Democratic-caucusing Independents have secured 55 Senate seats, compared with 44 for Republicans, and Alaska’s Senate race still has not been called. In the House, Democrats won 256 seats while Republicans won 169, with 10 races still outstanding. Overall, health care – specifically affordability – emerged as a prominent election issue, and several candidates from medical and public health backgrounds, including pediatrician Annie Andrews (D-SC) and former public health official Abdul El-Sayed (D-MI), won competitive Senate seats.
With Democrats gaining control of both chambers of Congress in 2027, substantial changes are expected in congressional leadership and key committees overseeing health care and federal funding. House Minority Leader Hakeem Jeffries (D-NY) is expected to become Speaker, while Senate Minority Leader Chuck Schumer (D-NY) is poised to become Majority Leader. Democrats will hold their leadership votes this week. On the appropriations committees, Senators Patty Murray (D-WA) and Tammy Baldwin (D-WI) are expected to chair the full Senate Appropriations Committee and its Labor-HHS-Education Subcommittee, respectively, while Representative Rosa DeLauro (D-CT) is expected to lead both the full appropriations committee and the Labor-HHS-Education Subcommittee in the House. Senator Bernie Sanders (I-VT) is positioned to chair the Senate Health, Education, Labor, and Pensions (HELP) Committee, while Representative Frank Pallone (D-NJ) is seeking to reclaim the chairmanship of the House Energy and Commerce Committee. We expect Senator Ron Wyden (D-OR) and Richard Neal (D-MA) to retake the gavels for the Senate Finance and Ways and Means Committees, respectively.
Senator John Thune (R-SD) will serve as the Senate Minority Leader, while Representative Jim Jordan (R-OH) beat Representative Steve Scalise (R-LA) to serve as House Minority Leader. Republican committee assignments remain unsettled, including a potential challenge by Senator Jerry Moran (R-KS) against Senator Lisa Murkowski (R-AK) for the top Republican position on Senate Appropriations. Murkowski remains the likely successor based on seniority, particularly after Senator Rand Paul (R-KY) announced his intention to serve as ranking member of the Senate HELP Committee, eliminating a potential alternative leadership position for Murkowski. The Republican’s top spot on the Appropriations Committee opened after Senator Susan Collins (R-ME) lost her re-election bid.
Lame-Duck Legislative Outlook and FY 2027 Funding Negotiations
Government funding is set to expire December 11. Top appropriators have begun discussions on fiscal year 2027 funding, and the Senate has recently released its FY 2027 Agriculture-Food and Drug Administration (FDA) and Military Construction-Veterans Affairs (VA) appropriations bills. However, disagreements remain over whether to enact full-year spending bills or extend current funding through a continuing resolution (CR) into the next Congress. Representative Rosa DeLauro (D-CT) and Senator Patty Murray (D-WA) have expressed support for a short-term CR that extends government funding into early 2027. Both Sen. Murray and Rep. DeLauro have also emphasized the need to use the appropriations process to block the Office of Management and Budget (OMB) proposed rule for grantmaking. Republicans face a narrowing window to advance their priorities, including pending judicial confirmations and the National Defense Authorization Act.
The lame-duck session could also provide an opportunity to address expiring health programs and other end-of-year health care priorities, although the scope of any legislative package remains uncertain. Looking ahead, the Democratic majorities are expected to place greater emphasis on health care affordability, Medicaid protections, prescription drug costs, federal health research funding, and oversight of the Trump administration’s health policies. However, with President Trump remaining in office (and elevating Stephen Miller to serve as his chief of staff) and Senate Democrats lacking a filibuster-proof majority, major legislative changes will require bipartisan negotiations.
Related News Articles
Health Policy News: November 2, 2026
This content is an exclusive benefit for SGIM members. If you’re a…
Health Policy News: October 5, 2026
This content is an exclusive benefit for SGIM members. If you’re a…
Health Policy News: September 21, 2026
This content is an exclusive benefit for SGIM members. If you’re a…